H1N1 vaccine production – H1N1 “Swine Flu” Vaccine Market Review (Revenues, Forecasts, Lessons for Future Pandemic Vaccines)
H1N1 “Swine Flu” Vaccine Market Review (Revenues, Forecasts, Lessons for Future Pandemic Vaccines)
The H1N1 flu epidemic made a public health emergency in 2009. It also made an opportunity for vaccine manufacturers to demonstrate that working with governments of the US and countries around the world, they could manufacture and distribute a vaccine for the virus strain that may have had an impact in reducing cases and deaths.
Who were the companies that performed best in this market? How did goverment contracts play out? Most importantly, what are lessons for future pandemic and high publicity vaccine products? Kalorama has looked at vaccine products over the past decade and has seen the rise of interest in these products among pharmaceutical companies. While many suggest the H1N1 was a one time event, Kalorama believes there is something vital to be gained in a market review of 2009 flu vaccine sales that will inform executives, investors and market watchers who are interested in the vaccine market.
This Kalorama Information report takes a detailed look at the H1N1 vaccine sales of 2009 based on available annual reports. Companies covered include AstraZeneca, Novartis, Glaxo and CSL among others. As part of its coverage, the report includes:
2009 H1N1 Vaccine Sales Results
Stockpiles, Returns, Delivery Systems and other Issues and Trends in Vaccine Sales
H1N1 Etiology and Statistics
Forecasts for 2010-2013 Influenza Vaccine Market
Trending in Government Contracts
Seasonal and H1N1 Flu Market Interplay
Conclusions for Future Pandemic Vaccine Sales
Market Share of Major Companies
Company Profiles
As part of its coverage, the following vaccine makers are profiled
Baxter Healthcare
GlaxoSmithKline
CSL
Medimmune (Astra Zeneca)
Merck & Co. Inc
Novartis
Sanofi Pasteur
Sinovac
Hualan Biological Engineering Co.
Novovax
This Kalorama Information report was made as the result of both secondary and primary research. Research was conducted into the annual reports of major vaccine concerns, trade media coverage, company websites and medical and government literature. Interviews were used to make forecasts on the vaccine market and the influenza vaccine market for 2010-2014, which have been utilized in our estimate of the swine flu vaccine market impact for the 2010-2014 years. Historical information for this report was gathered from a wide variety of published sources including company reports and filings, government documents, legal filings, trade journals, newspapers and business press, analysts’ reports and other sources.
ReportsandReports, comprising of an online library of 10,000 reports. H1N1 “Swine Flu” Vaccine Market Review (Revenues, Forecasts, Lessons for Future Pandemic Vaccines).Market Research Report now in store. Browse all our detailed market research report at ReportsandReports.com
The H1N1 flu epidemic made a public health emergency in 2009. It also made an opportunity for vaccine manufacturers to demonstrate that working with governments of the US and countries around the world, they could manufacture and distribute a vaccine for the virus strain that may have had an impact in reducing cases and deaths.
Article from articlesbase.com
Related H1N1 Vaccine Production Articles
Related posts:
- H1N1 vaccine production – H1N1 (Swine Influenza) – Pipeline Assessment and Market Forecasts to 2017
- Vaccine Immunity – Vaccines 2009: World Market Analysis, Key Players, And Critical Trends In A Fast-Changing Industry
- H1N1 vaccine production – Vaccines for swine flu, seasonal flu hard to find
- H1N1 vaccine production – Optimistic Prospect of Chinese A (H1N1) Influenza Vaccine Market
- H1N1 vaccine production – Advances in Vaccine Technology and Delivery
Leave a Reply
You must be logged in to post a comment.
